Results 121 to 130 of about 4,265 (181)
Some of the next articles are maybe not open access.
Documenta Ophthalmologica, 1983
A study was made of patients, who were receiving PUVA therapy for psoriasis, to see if lens abnormalities occurred which could be due to the PUVA treatment. In a group of 42 patients there was only one eye of one patient, in which a very slight opacity was found which might possibly have developed during the therapy.
C C, Sterk +2 more
exaly +3 more sources
A study was made of patients, who were receiving PUVA therapy for psoriasis, to see if lens abnormalities occurred which could be due to the PUVA treatment. In a group of 42 patients there was only one eye of one patient, in which a very slight opacity was found which might possibly have developed during the therapy.
C C, Sterk +2 more
exaly +3 more sources
Dermatologic Clinics, 1995
The goal of photochemotherapy in psoriasis is to attempt to lower the number of exposures and the total cumulative doses while still maintaining good control of the disease. PUVA has been modified by using better psoralen preparations and more effective light sources, and it also has been combined with other treatment modalities.
K, Momtaz-T, T B, Fitzpatrick
openaire +2 more sources
The goal of photochemotherapy in psoriasis is to attempt to lower the number of exposures and the total cumulative doses while still maintaining good control of the disease. PUVA has been modified by using better psoralen preparations and more effective light sources, and it also has been combined with other treatment modalities.
K, Momtaz-T, T B, Fitzpatrick
openaire +2 more sources
Dermatologic Clinics, 1995
The development in 1974 of psoralen photochemotherapy (PUVA) for severe psoriasis transformed the therapeutic setting for this disease from in-patient to ambulatory, presaging the trend in the past decade to reduce hospitalization. The prospective evaluation of this treatment in well-designed, well-controlled studies with the participation of a large ...
openaire +2 more sources
The development in 1974 of psoralen photochemotherapy (PUVA) for severe psoriasis transformed the therapeutic setting for this disease from in-patient to ambulatory, presaging the trend in the past decade to reduce hospitalization. The prospective evaluation of this treatment in well-designed, well-controlled studies with the participation of a large ...
openaire +2 more sources
PUVA-induced melanocytic atypia: Is it confined to PUVA lentigines?
Journal of the American Academy of Dermatology, 1985Widespread lentigines in fourteen patients following long-term therapy with psoralens and ultraviolet A (PUVA) for psoriasis were documented by biopsy of a representative lesion in a non-sun-exposed site. Chronically PUVA-exposed nonlesional skin was examined in ten of the fourteen patients.
E A, Abel, H, Reid, C, Wood, C H, Hu
openaire +2 more sources
PUVA treatment of scleromyxoedema
British Journal of Dermatology, 1984Treatment of a 60-year-old woman with scleromyxoedema with 8-methoxypsoralen and UV-A radiation (PUVA) resulted in significant clinical and histological improvement but no change in circulating paraprotein.
P M, Farr, F A, Ive
openaire +2 more sources
Cryotherapy of PUVA lentigines
British Journal of Dermatology, 1996PUVA lentigines do not subside after discontinuation of photochemotherapy. Cryotherapy with liquid nitrogen was done on a small area in a patient who presented with numerous PUVA lentigines. Five years after this treatment, the PUVA lentigines had not returned. Cosmetically disturbing PUVA lentigines can be treated with cryotherapy.
D, Leroy +3 more
openaire +2 more sources
2003
SüleymanDemirel Üniversitesi TIP FAKÜLTESİ DERGİSİ: 2004 Haziran; 11(2) PUVA Tedavisi Ali Murat Ceyhan, Mehmet Yıldırım ÖzetPUVA, psoralenle uzun dalga boylu ultraviyole ışığı olan UVA'nın kombinasyonu olup, dermatolojik hastalıkların sağaltımında önemli yeri olan bir tedavi yöntemidir.
Ceyhan, Ali Murat, Yıldırım, Mehmet
openaire +4 more sources
SüleymanDemirel Üniversitesi TIP FAKÜLTESİ DERGİSİ: 2004 Haziran; 11(2) PUVA Tedavisi Ali Murat Ceyhan, Mehmet Yıldırım ÖzetPUVA, psoralenle uzun dalga boylu ultraviyole ışığı olan UVA'nın kombinasyonu olup, dermatolojik hastalıkların sağaltımında önemli yeri olan bir tedavi yöntemidir.
Ceyhan, Ali Murat, Yıldırım, Mehmet
openaire +4 more sources
A comparison of PUVA-etretinate and PUVA-placebo for palmoplantar pustular psoriasis
British Journal of Dermatology, 1984Seventeen patients with palmoplantar pustular psoriasis and three with hyperkeratotic psoriasis of palms and soles were treated with either PUVA-etretinate (1 mg/kg) or PUVA-placebo. Patients were randomly allocated to each group and the trial was conducted according to a double-blind protocol, so far as the side-effects of etretinate made this ...
C M, Lawrence +3 more
openaire +2 more sources
Carcinogenic Risk of Bath PUVA in Comparison to Oral PUVA Therapy
Dermatology, 1999The potential carcinogenic risk of bath PUVA therapy was compared to that of systemic (oral) PUVA. An analysis of the epidemiological data on cancer risk following bath PUVA with trimethylpsoralen does not support the conclusion that bath PUVA per se is less carcinogenic than systemic PUVA with 8-methoxypsoralen (8-MOP).
Shephard SE, Panizzon RG
openaire +3 more sources